BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 6854944)

  • 1. [Studies on Clostridium difficile and antimicrobial associated diarrhea or colitis].
    Kobayashi T
    Jpn J Antibiot; 1983 Feb; 36(2):464-76. PubMed ID: 6854944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibility of Clostridium difficile isolates from patients with antibiotic-associated diarrhea or colitis.
    Dzink J; Bartlett JG
    Antimicrob Agents Chemother; 1980 Apr; 17(4):695-8. PubMed ID: 7396460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibility of Clostridium difficile isolates to 12 antimicrobial agents.
    Gianfrilli P; Luzzi I; Pantosti A; Occhionero M
    Chemioterapia; 1984 Feb; 3(1):41-4. PubMed ID: 6535652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibility of Clostridium difficile from different sources.
    Nakamura S; Nakashio S; Mikawa M; Yamakawa K; Okumura S; Nishida S
    Microbiol Immunol; 1982; 26(1):25-30. PubMed ID: 7087801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations.
    Viscidi R; Willey S; Bartlett JG
    Gastroenterology; 1981 Jul; 81(1):5-9. PubMed ID: 7239125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rate of isolation of "C. difficile" from stools of hospitalized patients: susceptibility of 75 strains (author's transl)].
    Tytgat F
    Ann Microbiol (Paris); 1980; 131B(1):11-20. PubMed ID: 7458111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Isolation of Clostridium difficile from the stools of hospitalized patients with diarrhea].
    de Barbeyrac B; Quentin C; Masse D; Bébéar C
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):672-5. PubMed ID: 3534766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of toxin gene diversity, molecular epidemiology, and antimicrobial resistance of Clostridium difficile isolated from 12 hospitals in South Korea.
    Kim H; Jeong SH; Roh KH; Hong SG; Kim JW; Shin MG; Kim MN; Shin HB; Uh Y; Lee H; Lee K
    Korean J Lab Med; 2010 Oct; 30(5):491-7. PubMed ID: 20890081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridium difficile-associated diarrhea and colitis.
    Gerding DN; Johnson S; Peterson LR; Mulligan ME; Silva J
    Infect Control Hosp Epidemiol; 1995 Aug; 16(8):459-77. PubMed ID: 7594392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridium difficile: prevalence in horses and environment, and antimicrobial susceptibility.
    Båverud V; Gustafsson A; Franklin A; Aspán A; Gunnarsson A
    Equine Vet J; 2003 Jul; 35(5):465-71. PubMed ID: 12875324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibilities of canine Clostridium difficile and Clostridium perfringens isolates to commonly utilized antimicrobial drugs.
    Marks SL; Kather EJ
    Vet Microbiol; 2003 Jun; 94(1):39-45. PubMed ID: 12742714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis.
    Bartlett JG; Moon N; Chang TW; Taylor N; Onderdonk AB
    Gastroenterology; 1978 Nov; 75(5):778-82. PubMed ID: 700321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incidence of nosocomial toxigenic clostridium difficile associated diarrhea in Tehran tertiary medical centers.
    Sadeghifard N; Salari MH; Ghassemi MR; Eshraghi S; Amin Harati F
    Acta Med Iran; 2010; 48(5):320-5. PubMed ID: 21287466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colitis induced by Clostridium difficile.
    Bartlett JG; Chang T; Taylor NS; Onderdonk AB
    Rev Infect Dis; 1979; 1(2):370-8. PubMed ID: 549188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emergence of metronidazole and vancomycin reduced susceptibility in Clostridium difficile isolates in Iran.
    Kouhsari E; Douraghi M; Krutova M; Fakhre Yaseri H; Talebi M; Baseri Z; Moqarabzadeh V; Sholeh M; Amirmozafari N
    J Glob Antimicrob Resist; 2019 Sep; 18():28-33. PubMed ID: 30703583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Clostridium difficile-associated diarrhea among patients hospitalized in tertiary care academic hospital.
    Martirosian G; Szczesny A; Cohen SH; Silva J
    Diagn Microbiol Infect Dis; 2005 Jun; 52(2):153-5. PubMed ID: 15964504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial agents implicated in Clostridium difficile toxin-associated diarrhea of colitis.
    Bartlett JG
    Johns Hopkins Med J; 1981 Jul; 149(1):6-9. PubMed ID: 7253364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of Clostridium difficile from diarrhoea patients in Bangladesh.
    Akhtar SQ
    J Trop Med Hyg; 1987 Aug; 90(4):189-92. PubMed ID: 3656496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudomembranous colitis: isolation of two species of cytotoxic clostridia and successful treatment with vancomycin.
    Marrie TJ; Faulkner RS; Badley BW; Hartlen MR; Comeau SA; Miller HR
    Can Med Assoc J; 1978 Nov; 119(9):1058-60. PubMed ID: 743667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Investigation of toxin genes of Clostridium difficile strains isolated from hospitalized patients with diarrhoea at Marmara University Hospital].
    Deniz U; Ulger N; Aksu B; Karavuş M; Söyletir G
    Mikrobiyol Bul; 2011 Jan; 45(1):1-10. PubMed ID: 21341153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.